7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Dr. Esra Karakaş Endocrinology · Acibadem Kayseri Hospital

Dr. Esra Karakaş

✓ Medically verified profile
Endocrinology · Acibadem Kayseri Hospital

Dr. Esra Karakaş

Dr. Esra Karakaş is an endocrinology specialist at Acibadem Kayseri Hospital in Kayseri, Turkey, working in Endocrinology & Metabolism. She manages thyroid disorders including hyperthyroidism, Graves’ disease, Hashimoto’s disease and goiter, prediabetes and gestational diabetes, and adrenal and pituitary conditions such as Addison’s disease, Cushing syndrome, acromegaly and diabetes insipidus. She consults in Turkish and English.

Medically verified profile 22+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Karakaş Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Dr. Esra KarakaşAccepting international patients
SpecialtyEndocrinology
ConsultationVideo · In person · Second opinion
Profile

About Dr. Esra Karakaş

Dr. Esra Karakaş is an endocrinology specialist at Acibadem Kayseri Hospital in Kayseri, where she works in the Endocrinology & Metabolism unit. Her clinical work covers thyroid disorders, diabetes-related conditions, and adrenal and pituitary hormone disorders. She has more than 22 years in medicine and speaks Turkish and English.

Dr. Karakaş graduated from Hacettepe University Faculty of Medicine in 2004. She completed her training in internal medicine at Ankara Numune Training and Research Hospital in 2011, followed by compulsory service in internal medicine at Yozgat Boğazlıyan State Hospital. From 2011 to 2017 she worked at the Mustafa Kemal University Division of Endocrinology and Metabolic Diseases, and in 2017 she completed her specialty training at Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine Department of Endocrinology and Metabolic Diseases. She then practiced as an endocrinology and metabolic diseases specialist at Kastamonu State Hospital from 2017 to 2019 and at Ordu Medical Park Hospital from 2019 to 2024, before joining Acıbadem Healthcare Services in 2024. She is a co-author of peer-reviewed publications on topics including metabolic syndrome, hypertension, and blood-based inflammatory markers in cardiovascular and oncological settings.

Clinical focus

Dr. Karakaş evaluates and manages a range of hormonal and metabolic conditions. In thyroid disease, her practice includes hyperthyroidism, Graves’ disease, Hashimoto’s disease, and goiter. In the area of glucose metabolism, she sees patients with prediabetes and gestational diabetes, with care planned according to the individual clinical picture.

Her work also covers disorders of the adrenal and pituitary glands. These include Addison’s disease, Cushing syndrome, acromegaly, and diabetes insipidus. Because these conditions often present with non-specific symptoms and require careful hormonal assessment, evaluation typically involves a detailed history, review of previous laboratory results and imaging, and a stepwise diagnostic approach before treatment options are discussed. The suitability of any treatment depends on the individual findings and is decided after assessment.

How Dr. Karakaş works with international patients

Dr. Karakaş consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments, and organises the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination, and a discussion of the options. For patients who are unable to travel initially, or who wish to discuss their case before deciding on a visit, video consultation is available for international patients. Recommendations made during a video consultation are based on the information provided and may be revised after an in-person examination and further testing.

Clinical focus

What Dr. Karakaş treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Background

Education, career and memberships

Education & training

Education

  • 2017Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine Department of Endocrinology and Metabolic Diseases
  • 2011Ankara Numune Training and Research Hospital Department of Internal Medicine
  • 2004Hacettepe University Faculty of Medicine
Career

Professional Experience

  • 2024Acıbadem Healthcare Services
  • 2019–2024Ordu Medical Park Hospital
  • 2017–2019Kastamonu State Hospital - Specialization in Endocrinology and Metabolic Diseases
  • 2011–2017Mustafa Kemal University - Division of Endocrinology and Metabolic Diseases
  • 2011Yozgat Boğazlıyan State Hospital- Compulsory Service in Internal Medicine Specialization
Selected publications

Selected Publications

  • Relation of red celi distribution width with dipper and non-dipper hypertension Med Glas (Zenica). 2016 Aug 1 ;13(2):75-81. doi: 10.17392/859-16. PubMed PMID: 27452327. Buyukkaya E, Erayman A, Karakas E, Buğra NacarA, Kurt M, Buyukkaya S, Burak Akcay A, Sen N.
  • Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients Contemp Oncol (Pozn). 2016;20(2):153-7. doi: 10.5114/wo.2016.60072. Epub 2016 Jun 14. PubMed PMID: 27358595; PubMed Central PMCID: PMC4925737. Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, Uncu HG, Ozdemir N, Zengin N.
  • Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer. Wien Klin VVochenschr. 2016 Sep;128(17-18):635-40. doi: 10.1007/S00508-015-0724-8. Epub 2015 Feb 27. PubMed PMID: 25720573. Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, Uncu HG, Yildirim N, Zengin N.
  • Assessment of Prognostic Value of “Neutrophil to Lymphocyte Ratio” and “Prognostic Nutritional Index” as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer Asian Pac J Cancer Prev. 2015;16(9):3997-4002. PubMed PMID: 25987075. Kos FT, Hocazade C, Kos M, Uncu D, Karakas E, Dogan M, Uncu HG, Ozdemir N, Zengin N.
  • Left ventricular dyssynchrony is an early manifestation of heart involvement in sickle cell anemia Echocardiography. 2013 May;30(5):521-6. doi: 10.1111/echo.12085. Epub2013 Jan 11. PubMed PMID: 23305504. Karakas MF, Buyukkaya E, Kurt M, Celik M, Karakas E, Buyukkaya S, Akcay AB, Sen N.
  • Serum pentraxin-3 levels are associated with the severity of metabolic syndrome. Med Princ Pract. 2013;22(3):274-9. doi: 10.1159/000343904. Epub2012 Nov 8. PubMed PMID: 23146973; PubMed Central PMCID: PMC5586734. Karakas MF, Buyukkaya E, Kurt M, Motor S, Akcay AB, Karakas E, Buyukkaya S, Sen N.
  • The serum pentraxin-3 is elevated in patients with cardiac syndrome X. Türk Kardiyol Dern Ars. 2013 Jun;41(4):290-5. doi: 10.5543/tkda.2013.20025. PubMed PMID: 23760115 Buyukkaya E, Karakas MF, Kurt M, Motor S, Akcay AB, Buyukkaya S, Karakas E, Sen N.
  • Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris J Investig Med. 2013 Feb;61(2):278-85. doi: 10.2310/JIM.0b013e31827c2971. PubMed PMID: 23237880 Karakas MF, Buyukkaya E, Kurt M, Motor S, Akcay AB, Buyukkaya S, Karakas E, Bilen P, Sen N.
  • Assessment of left ventricular dyssynchrony in dipper and non-dipper hypertension Blood Press. 2013 Jun;22(3):144-50. doi: 10.3109/08037051.2012.745224. Epub 2013 Mar 5. PubMed PMID: 23458091. Karakas MF, Buyukkaya E, Kurt M, Karakas E, Buyukkaya S, Akcay AB, Sen N.
  • Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome Buyukkaya E, Karakas MF, Karakas E, Akcay AB, Tanboga IH, Kurt M, Sen N.
Good to Know

Frequently Asked Questions

Which endocrine conditions does Dr. Karakaş treat?
Dr. Karakaş manages thyroid disorders such as hyperthyroidism, Graves’ disease, Hashimoto’s disease and goiter; glucose-related conditions including prediabetes and gestational diabetes; and adrenal and pituitary disorders such as Addison’s disease, Cushing syndrome, acromegaly and diabetes insipidus. The appropriate approach for each patient is determined after clinical assessment and review of test results.
Where does Dr. Karakaş practise?
Dr. Karakaş practises at Acibadem Kayseri Hospital in Kayseri, Turkey, within the Endocrinology & Metabolism unit. She joined Acıbadem Healthcare Services in 2024, after earlier positions at Ordu Medical Park Hospital, Kastamonu State Hospital, Mustafa Kemal University and Yozgat Boğazlıyan State Hospital.
Which languages does Dr. Karakaş speak with patients?
Dr. Karakaş consults in Turkish and English. For international patients who speak other languages, interpreters can be arranged through the Acibadem international patient team so that the consultation, test results and treatment options can be discussed clearly.
What should I send for a case review before my visit?
It is generally helpful to provide recent laboratory results, particularly hormone and glucose tests, any imaging reports and images, previous medical reports, and a list of current medications and past treatments. The international patient team coordinates the collection of these documents so that they can be reviewed before the first consultation.
What is Dr. Karakaş’s training background?
Dr. Karakaş graduated from Hacettepe University Faculty of Medicine in 2004, completed internal medicine training at Ankara Numune Training and Research Hospital in 2011, and completed specialty training at Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine Department of Endocrinology and Metabolic Diseases in 2017. She has more than 22 years in medicine.
Does Dr. Karakaş offer video consultations for international patients?
Yes, video consultation is available for international patients. This can be used to discuss symptoms, existing reports and possible next steps before travelling. Any recommendations given remotely are based on the information provided and may be revised after an in-person examination and further testing at the hospital.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.